Oral solution formulation of Vimpat available UCB announced that it has made available an oral solution formulation of Vimpat (lacosamide), an antiepileptic drug for the add-on treatment of ...
The FDA has assigned a Prescription Drug User Fee Act target date of February 25, 2026 to the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ET-600 ...
PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...
CD Formulation enables rapid product development success for the cosmetics industry through its complete one-stop solution as a top-tier biotechnology R&D company. Based in New York, CD Formulation ...
Newer polymer-based formulations of oral rehydration solution given to treat diarrhea may offer some benefits over older sugar-salt formulations. But, say researchers who carried out a review of the ...
This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions ...
ATLANTA, June 14, 2010 /EurekAlert/ -- UCB today announced the availability of an oral solution formulation of Vimpat® (lacosamide) C-V, an antiepileptic drug (AED) for add-on treatment of ...
SAN DIEGO, December 12, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. Food and Drug Administration (FDA) has approved DAYBUE ® STIX (trofinetide) for ...
New and reimagined products and smarter and more sustainable formulations showcase Univar Solutions' technical expertise, commitment to innovation DOWNERS GROVE, Ill., May 10, 2023 /PRNewswire/ -- ...
In food manufacturing, the right texture, balanced flavour and perfect stability are crucial. Functional ‘blends’ enhance these properties, tailoring food products to specific needs such as texture, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback